Chromatography in the detection and characterization of illegal pharmaceutical preparations

Journal of Chromatographic Science

Volumn 51, Issue 8, 2013, Pages 791-806

  Deconinck, Eric ^a   Sacré, Pierre Yves ^a,b   Courselle, Patricia ^a   De Beer, Jacques O ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COUNTERFEIT DRUG; STREET DRUG;

CHEMISTRY; CHROMATOGRAPHY; METHODOLOGY; REVIEW; SUBSTANCE ABUSE;

CHROMATOGRAPHY; COUNTERFEIT DRUGS; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 84882400187     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bmt006     Document Type: Review

References (212)

1. World Health Organization (WHO); Counterfeit drugs - Guidelines for the development of measures to combat counterfeit drugs. WHO/EDM/QSM/99.1. Geneva, Switzerland, (1999).
2. Newton, P., Green, M., Fernandè z, F., Day, N., White, N.; Counterfeit anti-infective drugs; The Lancet Infectious Diseases, (2006); 6: 602-613.
3. PRLOG, Press Release Distribution; Global Pharmaceutical Market Forecast to 2012, (2008); http://www.prlog.org/10124036-globalpharceutical- market-forcast-to-2012.html (accessed April 14, 2011).
4. Deisingh, A.; Pharmaceutical counterfeiting; Analyst, (2005); 130: 271-279.
5. World Health Organization (WHO); Counterfeit Drugs Kill, (2008); http://www.who.int/impact/FinalBrochureWHA2008a.pdf (accessed April 14, 2011).
6. Pharmaceutical Security Institute (2002); http://www.psi-inc.org (accessed August 20, 2012).
7. WHO; Medicines: Spurious/falsely-labelled/falsified/counterfeit (SFFC) medicines, (2012); http://www.who.int/mediacentre/factsheets/ fs275/en/index.html (accessed April 14, 2011).
8. PRLOG, Press Release Distribution; Global Pharmaceutical Market Forecast to 2012, (2008); http://www.prlog.org/10124036-globalpharmaceutical- market-forecast-to-2012.html (accessed April 14, 2011).
9. U.S. Food and Drug Administration; Counterfeit Medicines, (2012); http://www.fda.gov/Drugs/ResourcesForYou/Consumers/Buying UsingMedicineSafely/ CounterfeitMedicine/default.htm.
10. Clift, C.; Combating counterfeit, falsified and substandard medicines defining the way forward? Chatham House Briefing Papers, (2010).
11. European Alliance For Access to Safe Medicines. http://www. eaasm.eu.
12. European Medicine Evaluation Agency (2009); http://www. emea.europa.eu/docs/en-GB/document-library/Regulatory- and-procedural-guideline/ 2009/10/WC500004481.pdf. (accessed August 20, 2012).
13. Council of Europe; Counterfeiting of medicinal products (Medicrime), (2011); http://www.coe.int/medicrime. (accessed August 20, 2012).
14. WHO. (2009) Sixty-second World Health Assembly Item 12.9: Counterfeit medical products. http://aps.who.int/gb/ebhwa/pdf- files/A62/A62-13-en.pdf.
15. European Parlement (2011); http://www.europarl.europe.eu/ sides/getDoc.do?pubRef=-//EP//TEXT+TA+P7-TA-2011-0056+ 0+DOC+XML+V0//EN (accessed April 14, 2011).
16. Venhuis, B.J., Barends, D.M., Zwaagstra, M.E., de Kaste, D.; Recent developments in counterfeit and imitations of Viagra, Cialis and Levitra, RIVM report 370030001/2007, Bilthoven, (2007).
17. WHO; Counterfeit Drugs Kill, (2008); http://www.who.int/ impact/finalbrochureWHA2008a.pdf (accessed April 14, 2011).
18. Securing Industry; EU Illicit trade in medicines could top at 10.5 billion Euro, says survey, (2010); http://www.securingpharma. com/40/articles/378.php (accessed April 14, 2011).
19. WHO; Growing threat from counterfeit medicines, (2009); http:// www.who.int/bulletin/volumes/88/4/10-020410.pdf (accessed April 14, 2011).
20. Blok-Tip, L., Vogelpoel, H., Vredenbregt, M.J., Barends, D.M., de Kast, D.; Counterfeit and imitations of Viagra and Cialis tablets: Trends and risks to public health, RIVM report 267041001/2005, Bilthoven, (2005).
21. Federal Agency for Medicines and Health Products; Belgian participation in Pangea III, an international operation fighting against the online sale of counterfeit and illegal medicines, (2010); http://www.fagg-afmps.be/fr/news/ news-pangea-III.jsp (accessed April 14, 2011).
22. WHO; General information on counterfeit medicines, factors encouraging counterfeiting of drugs, (2011); http://www.who.int/ medicines/services/ counterfeit/overview/en/index1.html (accessed April 14, 2011).
23. Liang, Q., Qu, J., Luo, G., Wang, Y.; Rapid and reliable determination of illegal adulterant in herbal medicines and dietary supplements by LC/MS/MS; Journal of Pharmaceutical and Biomedical Analysis, (2006); 40: 305-311.
24. Cianchino, V., Acosta, G., Ortega, C., Martínez, L.D., Gomez, M.R.; Analysis of potential adulteration in herbal medicines and dietary supplements for the weight control by capillary electrophoresis; Food Chemistry, (2008); 108: 1075-1081.
25. Holzgrabe, U., Malet-Martino, M.; Analytical challenges in drug counterfeiting and falsification - The NMR approach; Journal of Pharmaceutical and Biomedical Analysis, (2011); 55: 679-687.
26. Venhuis, B.J., de Kaste, D.; Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks; Journal of Pharmaceutical and Biomedical Analysis, (2012); 69: 196-208.
27. Martino, R., Malet-Martino, M., Gilard, V.; Counterfeit drugs: Analytical techniques for their identification; Analytical and Bioanalytical Chemistry, (2010); 398: 77-92.
28. Venhuis, B.J., Zomer, G., de Kaste, D.; Structure elucidation of a novel synthetic thiono analogue of sildenafil detected in an alleged herbal aphrodisiac; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 814-817.
29. Venhuis, B.J., Zomer, G., Hamzink, M., Meiring, H.D., Aubin, Y., de Kaste, D.; The identification of a nitrosated prodrug of the PDE-5 inhibitor aildenafil in a dietary supplement: A Viagra with a pop; Journal of Pharmaceutical and Biomedical Analysis, (2011); 54: 735-741.
30. Sacré, P-Y., Deconinck, E., De Beer, T., Courselle, P., Vancauwenberghe, R., Chiap, P., et al.; Comparison and combination of spectroscopic techniques for the detection of counterfeit medicines; Journal of Pharmaceutical and Biomedical Analysis, (2010); 53: 445-453.
31. Ricci, C., Nyadong, L., Fernandez, F.M., Newton, P.N., Kazarian, S.G.; Combined Fourier-transform infrared imaging and desorption electrospray- ionization linear ion-trap mass spectrometry for analysis of counterfeit antimalarial tablets; Analytical & Bioanalytical Chemistry, (2007); 387: 551-559.
32. Vredenbregt, M.J., Blok-Tip, L., Hoogerbrugge, R., Barends, D.M., de Kaste, D.; Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy; Journal of Pharmaceutical and Biomedical Analysis, (2006); 40: 840-849.
33. Been, F., Roggo, Y., Degardin, K., Esseiva, P., Margot, P.; Profiling of counterfeit medicines by vibrational spectroscopy; Forensic Science International, (2011); 211: 83-100.
34. Dowell, F.E., Maghirang, E.B., Fernandez, F.M., Newton, P.N., Green, M.D.; Detecting counterfeit antimalarial tablets by near-infrared spectroscopy; Journal of Pharmaceutical and Biomedical Analysis, (2008); 48: 1011-1014.
35. da Silva Fernandes, R., da Costa, F.S., Valderrama, P., Març o, P.H., de Lima, K.M.; Non-destructive detection of adulterated tablets of glibenclamide using NIR and solid-phase fluorescence spectroscopy and chemometric methods; Journal of Pharmaceutical and Biomedical Analysis, (2012); 66: 85-90.
36. Storme-Paris, I., Rebiere, H., Matoga, M., Civade, C., Bonnet, P.A., Tissier, M.H., et al.; Challenging near infrared spectroscopy discriminating ability for counterfeit pharmaceuticals detection; Analytica Chimica Acta,(2010); 658: 163-174.
37. de Veij, M., Deneckere, A., Vandenabeele, P., de Kaste, D., Moens, L.; Detection of counterfeit Viagra with Raman spectroscopy; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 303-309.
38. Trefi, S., Routaboul, C., Hamieh, S., Gilard, V., Malet-Martino, M., Martino, R.; Analysis of illegally manufactured formulations of tadalafil (Cialis) by 1H NMR, 2D DOSY 1H NMR and Raman spectroscopy; Journal of Pharmaceutical and Biomedical Analysis, (2008); 47: 103-113.
39. Sacré, P.-Y., Deconinck, E., Saerens, L., De Beer, T., Courselle, P., Vancauwenberghe, R., et al.; Detection of counterfeit Viagra by Raman microspectroscopy imaging and multivariate analysis; Journal of Pharmaceutical and Biomedical Analysis, (2011); 56: 454-461.
40. Dégardin, K., Roggo, Y., Been, F., Margot, P.; Detection and chemical profiling of medicine counterfeits by Raman spectroscopy and chemometrics; Analytica Chimica Acta, (2011); 705: 334-341.
41. Ricci, C., Nyadong, L., Yang, F., Fernandez, F.M., Brown, C.D., Newton, P.N., et al.; Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry; Analytica Chimica Acta, (2008); 623: 178-186.
42. Maurin, J.K., Pluciński, F., Mazurek, A.P., Fijalek, Z.; The usefulness of simple X-ray powder diffraction analysis for counterfeit control - The Viagra example; Journal of Pharmaceutical and Biomedical Analysis, (2007); 43: 1514-1518.
43. Amin, A.S., Moustafa, M.E., El-Dosoky, R.; Colorimetric determination of sildenafil citrate (Viagra) through ion-associate complex formation; Journal of AOAC International, (2009); 92: 125-130.
44. Rodomonte, A.L., Gaudiano, M.C., Antoniella, E., Lucente, D., Crusco, V., Bartolomei, M., et al.; Counterfeit drugs detection by measurement of tablets and secondary packaging colour; Journal of Pharmaceutical and Biomedical Analysis, (2010); 53: 215-220.
45. Green, M.D., Mount, D.L., Wirtz, R.A., White, N.J.; A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate; Journal of Pharmaceutical and Biomedical Analysis, (2000); 24: 65-70.
46. Green, M.D., Mount, D.L., Wirtz, R.A.; Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method; Tropical Medicine & International Health, (2001); 6: 980-982.
47. Green, M.D., Nettey, H., Villalva Rojas, O., Pamanivong, C., Khounsaknalath, L., Grande Ortiz, M., et al.; Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality; Journal of Pharmaceutical and Biomedical Analysis, (2007); 43: 105-110.
48. Wawer, I., Pisklak, M., Chilmonczyk, Z.; 1H, 13C, 15N NMR analysis of sildenafil base and citrate (Viagra) in solution, solid state and pharmaceutical dosage forms; Journal of Pharmaceutical and Biomedical Analysis, (2005); 38: 865-870.
49. Nyadong, L., Harris, G.A., Balayssac, S., Galhena, A.S., Malet-Martino, M., Martino, R., et al.; Combining two-dimensional diffusion-ordered nuclear magnetic resonance spectroscopy, imaging desorption electrospray ionization mass spectrometry, and direct analysis in real-time mass spectrometry for the integral investigation of counterfeit pharmaceuticals; Analytical Chemistry, (2009); 81: 4803-4812.
50. Venhuis, B.J., Zomer, G., Vredenbregt, M.J., de Kaste, D.; The identification of (-)-trans-tadalafil and sildenafil in counterfeit Cialis and the optical purity of tadalafil stereoisomers; Journal of Pharmaceutical and Biomedical Analysis, (2010); 51: 723-727.
51. Vaysse, J., Gilard, V., Balayssac, S., Zedde, C., Martino, R., Malet-Martino, M.; Identification of a novel sildenafil analogue in an adulterated herbal supplement; Journal of Pharmaceutical and Biomedical Analysis, (2012); 59: 58-66.
52. Wollein, U., Eisenreich, W., Schramek, N.; Identification of novel sildenafil-analogues in an adulterated herbal food supplement; Journal of Pharmaceutical and Biomedical Analysis, (2011); 56: 705-712.
53. Ge, X., Li, L., Koh, H.L., Low, M.Y.; Identification of a new sildenafil analogue in a health supplement; Journal of Pharmaceutical and Biomedical Analysis, (2011); 56: 491-496.
54. Gratz, S.R., Zeller, M., Mincey, D.W., Flurer, C.L.; Structural characterization of sulfoaildenafil, an analog of sildenafil; Journal of Pharmaceutical and Biomedical Analysis, (2009); 50: 228-231.
55. Reepmeyer, J.C., d'Avignon, D.A.; Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs; Journal of Pharmaceutical and Biomedical Analysis, (2009); 49: 145-150.
56. Zou, P., Hou, P., Oh, S.S., Chong, Y.M., Bloodworth, B.C., Low, M.Y., et al.; Isolation and identification of thiohomosildenafil and thiosildenafil in health supplements; Journal of Pharmaceutical and Biomedical Analysis, (2008); 47: 279-284.
57. Reepmeyer, J.C., Woodruff, J.T.; Use of liquid chromatographymass spectrometry and a chemical cleavage reaction for the structure elucidation of a new sildenafil analogue detected as an adulterant in an herbal dietary supplement; Journal of Pharmaceutical and Biomedical Analysis, (2007); 44: 887-893.
58. Lin, M.C., Liu, Y.C., Lin, J.H.; Identification of a sildenafil analogue adulterated in two herbal food supplements; Journal of Food & Drug Analysis, (2006); 14: 260-264.
59. Lai, K.C., Liu, Y. C., Tseng, M.C., Lin, J. H.; Isolation and identification of a sildenafil analogue illegally added in dietary supplements; Journal of Food & Drug Analysis, (2006); 14: 19-23.
60. Shin, C., Hong, M., Kim, D., Lim, Y.; Structure determination of a sildenafil analogue contained in commercial herb drinks; Magnetic Resonance in Chemistry, (2004); 42: 1060-1062.
61. Hou, P., Zou, P., Low, M.Y., Chan, E., Koh, H.L.; Structural identification of a new acetildenafil analogue from pre-mixed bulk powder intended as a dietary supplement; Food Additives & Contaminants, (2006); 23: 870-875.
62. Blok-Tip, L., Zomer, B., Bakker, F., Hartog, K.D., Hamzink, M., Ten Hove, J., et al.; Structure elucidation of sildenafil analogues in herbal products; Food Additives & Contaminants, (2004); 21: 737-748.
63. Shin, M.H., Hong, M.K, Kim, W.S, Lee, Y.J., Jeoung, Y.C.; Identification of a new analogue of sildenafil added illegally to a functional food marketed for penile erectile dysfunction; Food Additives & Contaminants, (2003); 20: 793-796.
64. Toomey, V.M., Litzau, J.J., Flurer, C.L.; Isolation and structural characterization of two tadalafil analogs found in dietary supplements; Journal of Pharmaceutical and Biomedical Analysis, (2012); 59: 50-57.
65. Häberli, A., Girard, P., Low, M.Y., Ge, X.; Isolation and structure elucidation of an interaction product of aminotadalafil found in an illegal health food product; Journal of Pharmaceutical and Biomedical Analysis, (2010); 53: 24-28.
66. Lam, Y.H., Poon, W.T., Lai, C.K., Chan, A.Y., Mak, T.W., Identification of a novel vardenafil analogue in herbal product; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 804-807.
67. Lai, K.C., Liu, Y.C., Tseng, M.C., Lin, Y.L., Lin, J.H.; Isolation and identification of a vardenafil analogue in a dietary supplement; Journal of Food & Drug Analysis, (2007); 15: 220-227.
68. Lee, H.M., Kim, C.S., Jang, Y.M., Kwon, S.W., Lee, B.J.; Separation and structural elucidation of a novel analogue of vardenafil included as an adulterant in a dietary supplement by liquid chromatography-electrospray ionization mass spectrometry, infrared spectroscopy and nuclear magnetic resonance spectroscopy; Journal of Pharmaceutical and Biomedical Analysis, (2011); 54: 491-496.
69. Reepmeyer, J.C., Woodruff, J.T.; Use of liquid chromatographymass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a "natural" herbal dietary supplement; Journal of Chromatography A, (2006); 1125: 67-75.
70. Hasegawa, T., Takahashi, K., Saijo, M., Ishii, T., Nagata, T., Kurihara, M., et al.; Isolation and structural elucidation of cyclopentynafil and N-octylnortadalafil found in a dietary supplement; Chemical & Pharmaceutical Bulletin (Tokyo), (2009); 57: 185-189.
71. Ge, X., Low, M.Y., Zou, P., Lin, L., Yin, S.O., Bloodworth, B.C., et al.; Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplement; Journal of Pharmaceutical and Biomedical Analysis, (2008); 48: 1070-1075.
72. Choi, D.M., Park, S., Yoon, T.H., Jeong, H.K., Pyo, J.S., Park, J., et al., Determination of analogs of sildenafil and vardenafil in foods by column liquid chromatography with a photodiode array detector, mass spectrometry, and nuclear magnetic resonance spectrometry; Journal of AOAC International, (2008); 91: 580-588.
73. Park, H.J., Jeong, H.K., Chang, M.I., Im, M.H., Jeong, J.Y., Choi, D.M., et al.; Structure determination of new analogues of vardenafil and sildenafil in dietary supplements; Food Additives & Contaminants, (2007); 24: 122-129.
74. Gratz, S.R., Gamble, B.M., Flurer, R.A.; Accurate mass measurement using Fourier transform ion cyclotron resonance mass spectrometry for structure elucidation of designer drug analogs of tadalafil, vardenafil and sildenafil in herbal and pharmaceutical matrices; Rapid Communications in Mass Spectrometry, (2006); 20: 2317-2327.
75. de Peinder, P., Vredenbregt, M.J., Visser, T., de Kaste, D.; Detection of lipitor counterfeits: A comparison of NIR and Raman spectroscopy in combination with chemometrics; Journal of Pharmaceutical and Biomedical Analysis, (2008); 47: 688-694.
76. Deconinck, E., Sacré, P.-Y., Coomans, D., De Beer, J.; Classification trees based on infrared spectroscopic data to discriminate between genuine and counterfeit medicines; Journal of Pharmaceutical and Biomedical Analysis, (2012); 57: 68-75.
77. Kwok, K., Taylor, L.S.; Analysis of counterfeit Cialis tablets using Raman microscopy and multivariate curve resolution; Journal of Pharmaceutical and Biomedical Analysis, (2012); 66: 126-135.
78. Ortiz, R.S., Mariotti, K.C., Schwab, N.V., Sabin, G.P., Rocha, W.F., de Castro, E.V., et al.; Fingerprinting of sildenafil citrate and tadalafil tablets in pharmaceutical formulations via X-ray fluorescence (XRF) spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2012); (58): 7-11.
79. Pachaly, P., Schick, W.; Simple thin-layer chromatographic identification of active principles in finished products; Pharmazeutische Industrie, (1993); 55: 259-267.
80. Hadzija, B.W., Mattocks, A.M.; Simple techniques to detect and identify phentermine adulteration; Forensic Science International, (1983); 23: 143-147.
81. Hu, C.Q., Zou, W.B., Hu, W.S., Ma, X.K., Yang, M.Z., Zhou, S.L., et al.; Establishment of a fast chemical identification system for screening of counterfeit drugs of macrolide antibiotics; Journal of Pharmaceutical and Biomedical Analysis, (2006); 40: 68-74.
82. Moriyasu, T., Shigeoka, S., Kishimoto, K., Ishikawa, F., Nakajima, J., Kamimura, H., et al.; Identification system for Sildenafil in health foods; Yakugaku Zasshi; (2001), 121: 765-769.
83. Singh, S., Prasad, B., Savaliya, A.A., Shah, R.P., Gohil, V.M., Kaur, A.; Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs; Trends in Analytical Chemistry, (2009); 28: 13-28.
84. Reddy, T.S., Reddy, A.S., Devi, P.S.; Quantitative determination of sildenafil citrate in herbal medicinal formulations by highperformance thin-layer chromatography; Journal of Planar Chromatography - Modern TLC, (2006); 19: 427-431.
85. Shewiyo, D.H., Kaale, E., Risha, P.G., Dejaegher, B., Smeyers-Verbeke, J., Vander Heyden, Y.; Development and validation of a normal-phase high-performance thin layer chromatographic method for the analysis of sulfamethoxazole and trimethoprim in cotrimoxazole tablets; Journal of Chromatography A, (2009); 1216: 7102-7107.
86. Shewiyo, D.H., Kaale, E., Ugullum, C., Sigonda, M.N., Risha, P.G., Dejaegher, B., et al.; Development and validation of a normalphase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets; Journal of Pharmaceutical and Biomedical Analysis, (2011); 54: 445-450.
87. Wu, Y.W.; The identification of microscopic, physical and chemistrical analysis on Curculigo orchiode and its counterfeit; Zhong Yao Cai, (2006); 29: 553-554.
88. Pribluda, V.S., Barajos, A., An? ez, A., López, C.G., Figueroa, R., Herrera, R., et al.; Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: Results for the 2005-2010 period, Malaria Journal, (2012); 11: 202-213.
89. Nagaraju, V., Sreenath, D., Tirumala Rao, J., Nageswara Rao, R.; Separation of synthetic impurities of sildenafil (Viagra) by reversedphase high-performance liquid chromatography; Analytical Sciences, (2003); 19: 1007-1011.
90. Park, M., Ahn, S.; Quantitative analysis of sildenafil and tadalafil in various fake drugs recently distributed in Korea; Journal of Forensic Science, (2012); 57: 1637-1640.
91. Sacré, P.-Y., Deconinck, E., Chiap, P., Crommen, J., Mansion, F., Rozet, E., et al.; Development and validation of a UHPLC-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicines; Journal of Chromatography A, (2011); 1218: 6439-6447.
92. Gratz, S.R., Flurer, C.L., Wolnik, K.A.; Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV; Journal of Pharmaceutical and Biomedical Analysis, (2004); 36: 525-533.
93. Tomic, S., Micic, N., Sokolic, M., Martinac, A.I.; Identification of counterfeit medicines for erectile dysfunction from an illegal supply chain; Arhiv za Higijenu Rada i Toksikologiju, (2010); 61: 69-75.
94. De Orsi, D., Pellegrini, M., Marchei, E., Nebuloni, P., Gallinella, B., Scaravelli, G., et al.; High performance liquid chromatographydiode array and electrospray-mass spectrometry analysis of vardenafil, sildenafil, tadalafil, testosterone and local anesthetics in cosmetic creams sold on the Internet web sites; Journal of Pharmaceutical and Biomedical Analysis, (2009); 50: 362-369.
95. Savaliya, A.A., Shah, R.P., Prasad, B., Singh, S.; Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC-MS/TOF; Journal of Pharmaceutical and Biomedical Analysis, (2010); 52: 406-409.
96. Zou, P., Oh, S.S., Hou, P., Low, M.Y., Koh, H.L.; Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrospray ionization tandem mass spectrometry; Journal of Chromatography A, (2006); 1104: 113-122.
97. Amin, A.A., Snow, R.W., Kokwaro, G.O.; The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector; Journal of Clinical Pharmacy and Therapeutics, (2005); 30: 559-565.
98. United States Pharmacopoeia 35. United States Pharmacopoeial Convention, Inc., Rockville, MD, (2010).
99. Gaudiano, M.C., Antoniella, E., Bertocchi, P., Valvo, L.; Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines; Journal of Pharmaceutical and Biomedical Analysis, (2006); 42: 132-135.
100. Debrus, B., Lebrun, P., Kindenge, J.M., Lecomte, F., Ceccato, A., Caliaro, G., et al.; Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space; Journal of Chromatography A, (2011); 1218: 5205-5215.
101. Gaudiano, M.C., Di Maggio, A., Antoniella, E., Valvo, L., Bertocchi, P., Manna, L., et al.; An LC method for the simultaneous screening of some common counterfeit and sub-standard antibiotics: Validation and uncertainty estimation; Journal of Pharmaceutical and Biomedical Analysis, (2008); 48: 303-309.
102. Schad, G.J., Allanson, A., Mackay, S.P., Cannavan, A., Tettey, J.N.; Development and validation of an improved HPLC method for the control of potentially counterfeit isometamidium products; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 45-51.
103. Kim, S.H., Lee, J., Yoon, T., Choi, J., Choi, D., Kim, D., et al.; Simultaneous determination of anti-diabetes/anti-obesity drugs by LC/PDA, and targeted analysis of sibutramine analog in dietary supplement by LC/MS/MS; Biomedical Chromatography, (2009); 23: 1259-1265.
104. Stypulkowska, K., Blazewicz, A., Maurin, J., Sarna, K., Fijalek, Z.; X-ray powder difractometry and liquid chromatography studies of sibutrmine and its analogues content in herbal dietary supplements; Journal of Pharmaceutical and Biomedical Analysis, (2011); 56: 969-975.
105. Almeida, A.E., Ribeiro, M.L., Polese, L.; Determination of amfepramone hydrochloride, femproporex, and diazepam in so-called "natural" capsules used in the treatment of obesity; Journal of Liquid Chromatography & Related Technologies, (2000); 23: 1109-1118.
106. Almeida, A.E., Ribeiro, M.L.; High-performance liquid chromatographic determination of amfepramone hydrochloride, mazindol, and diazepam in tablets; Journal of Liquid Chromatography & Related Technologies, (1999); 22: 1759-1769.
107. Mikami, E., Goto, T., Ohno, T., Oka, H., Kanamori, H.; Simultaneous analysis of seven benzodiazepines in dietary supplements as adulterants using high performance liquid chromatography and its application to an identification system for diazepam; Journal of Health Science, (2005); 51: 278-283.
108. Deconinck, E., Verlinde, K., Courselle, P., Beer, J.O.; A validated ultra high pressure liquid chromatographic method for the characterisation of confiscated illegal slimming products containing anorexics; Journal of Pharmaceutical and Biomedical Analysis, (2012); 59: 38-43.
109. Liu, S.-Y., Woo, S.-O., Koh, H.-L.; HPLC and GC-MS screening of Chinese proprietary medicine for undeclared therapeutic substances; Journal of Pharmaceutical and Biomedical Analysis, (2001); 24: 983-992.
110. Gryniewicz, C.M., Reepmeyer, J.C., Kauffman, J.F., Buhse, L.F.; Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2009); 49: 601-606.
111. Zhu, X., Xiao, S., Chen, B., Zhang, F., Yao, S., Wan, Z., et al.; Simultaneous determination of sildenafil, vardenafil and tadalafil as forbidden components in natural dietary supplements for male sexual potency by high-performance liquid chromatography-electrospray ionization mass spectrometry; Journal of Chromatography A, (2005); 1066: 89-95.
112. Fleshner, N., Harvey, M., Adomat, H., Wood, C., Eberding, A., Hersey, K., et al.; Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors; Journal of Urology, (2005); 174: 636-641.
113. Li, L., Low, M.Y., Ge, X., Bloodworth, B.C., Koh, H.L.; Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement; Journal of Pharmaceutical and Biomedical Analysis, (2009); 50: 724-728.
114. Dorlo, T.P., Eggelte, T.A., de Vries, P.J., Beijnen, J.H.; Characterization and identification of suspected counterfeit miltefosine capsules; Analyst, (2012); 137: 1265-1274.
115. Dai, X.M., An, N., Wu, J.M., Li, H.Y., Zhang, Q.M.; Development and validation of HPLC-UV-MS method for the control of four antidiabetic drugs in suspected counterfeit products; Yao Xue Xue Bao, (2010); 45: 347-352.
116. Tang, M.H., Chen, S.P., Ng, S.W., Chan, A.Y., Mak, T.W.; Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected; British Journal of Clinical Pharmacology, (2011); 71: 250-253.
117. Venhuis, B.J., Vredenbregt, M.V., Kaun, N., Maurin, J.K., Fijalek, Z., de Kaste, D.; The identification of rimonabant polymorphs, sibutramine and analogues of both in counterfeit Acomplia bought on the internet; Journal of Pharmaceutical and Biomedical Analysis, (2011); 54: 21-26.
118. Wang, J., Chen, B., Yao, S.; Analysis of six synthetic adulterants in herbal weight-reducing dietary supplements by LC electrospray ionization-MS; Food Additives & Contaminants: Part A, (2008): 822-830.
119. Bogusz, M.J., Hassan, H., Al-Enazi, E., Ibrahim, Z., Al-Tufail, M.; Application of LC-ESI-MS-MS for detection of synthetic adulterants in herbal remedies; Journal of Pharmaceutical and Biomedical Analysis, (2006); 41: 554-564.
120. Chen, Y., Zhao, L., Lu, F., Yu, Y., Chai, Y., Wu, Y.; Determination of synthetic drugs used to adulterate botanical dietary supplements using QTRAP LC-MS/MS; Food Additives & Contaminants: Part A, (2009); 26: 595-603.
121. de Carvalho, L.M., Martini, M., Moreira, A.P., de Lima, A.P., Correia, D., Falca?o, T., et al.; Presence of synthetic pharmaceuticals as adulterants in slimming phytotherapeutic formulations and their analytical determination; Forensic Science International, (2011); 204: 6-12.
122. Hall, K.A., Newton, P.N., Green, M.D., De Veij, M., Vandenabeele, P., Pizzanelli, D., et al.; Characterization of counterfeit artesunate antimalarial tablets from southeast Asia; The American Journal of Tropical Medicine and Hygiene, (2006); 75: 804-811.
123. IUPAC compendium of chemical terminology. Royal Society of Chemistry, Cambridge, UK, (1997).
124. Tistaert, C., Dejaegher, B., Vander Heyden, Y.; Chromatographic separation techniques and data handling methods for herbal fingerprints: A review; Analytica Chimica Acta, (2011); 690: 148-161.
125. European Pharmacopoeia 7.0. Council of Europe, Strasbourg, France, (2010).
126. Japanese Pharmacopoeia, 16th ed. Society of Japanese Pharmacopoeia, Tokyo, (2011).
127. Hubert, M., Rousseeuw, P.J., Verboven, S.; A fast method for robust principal components with applications to chemometrics; Chemometrics and Intelligent Laboratory Systems, (2002); 60: 101-111.
128. Chen, Y., Zhu, S.B., Xie, M.Y., Nie, S.P., Liu, W., Li, C., et al.; Quality control and original discrimination of Ganoderma lucidum based on high-performance liquid chromatographic fingerprints and combined chemometrics methods; Analytica Chimica Acta, (2008); 623: 146-156.
129. Gan, F., Ye, R.; New approach on similarity analysis of chromatographic fingerprint of herbal medicine; Journal of Chromatography A, (2006); 1104: 100-105.
130. Li, B.Y., Hua, Y., Liang, Y.Z., Xie, P.S., Duc, Y.P.; Quality evaluation of fingerprints of herbal medicine with chromatographic data; Analytica Chimica Acta, (2004); 514: 69-77.
131. Xie, P., Chen, S., Liang, Y.Z., Wang, X., Tian, R., Upton, R.; Chromatographic fingerprint analysis - A rational approach for quality assessment of traditional Chinese herbal medicine; Journal of Chromatography A, (2006); 1112: 171-180.
132. Daszykowski, M., Vander Heyden, Y., Walczak, B.; Robust partial least squares model for prediction of green tea antioxidant capacity from chromatograms; Journal of Chromatography A, (2007), 1176: 12-18.
133. van Nederkassel, A.M., Daszykowski, M., Massart, D.L., Vander Heyden, Y.; Prediction of total green tea antioxidant capacity from chromatograms by multivariate modeling; Journal of Chromatography A, (2005); 1096: 177-186.
134. Tistaert, C., Dejaegher, B., Nguyen Hoai, N., Chataigné, G., Riviè re, C., Nguyen, T.H., et al.; Potential antioxidant compounds in Mallotus species fingerprints. Part I: Indication, using linear multivariate calibration techniques; Analytica Chimica Acta, (2009); 652: 189-197.
135. Tistaert, C., Dejaegher, B., Chataigné, G., Riviè re, C., Chau Van, M., Quetin-Leclercq, J., et al.; Potential antioxidant compounds in Mallotus species fingerprints. Part II: Alignment, Analysis and identification; Analytica Chimica Acta, (2012); 721: 35-43.
136. Tistaert, C., Dejaegher, B., Chataigné, G., van Minh, C., Quetin-Leclercq, J., Vander Heyden, Y.; Dissimilar chromatographic systems to indicate and identify antioxidants from Mallotus species; Talanta, (2011); 83: 1198-1208.
137. Tian, R.T., Xie, P.S., Liu, H.P.; Evaluation of traditional Chinese herbal medicine: Chaihu (Bupleuri Radix) by both highperformance liquid chromatographic and high-performance thinlayer chromatographic fingerprint and chemometric analysis; Journal of Chromatography A, (2009): 1216: 2150-2155.
138. Chopra, S., Ahmad, F.J., Khar, R.K., Motwani, S.K., Mahdi, S., Iqbal, Z., et al.; Validated high-performance thin-layer chromatography method for determination of trigonelline in herbal extract and pharmaceutical dosage form; Analytica Chimica Acta, (2006); 577: 46-51.
139. Kaur, A.D., Ravichandran, V., Jain, P.K., Agrawal, R.K.; High-performance thin layer chromatography method for estimation of conessine in herbal extract and pharmaceutical dosage formulations; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 391-394.
140. Apers, S., Naessens, T., Pieters, L., Vlietinck, A.; Densitometric thinlayer chromatographic determination of aescin in a herbal medicinal product containing Aesculus and Vitis dry extracts; Journal of Chromatography A, (2006); 1112: 165-170.
141. Marchand, E., Atemnkeng, M.A., Vanermen, S., Plaizier-Vercammen, J.; Development and validation of a simple thin layer chromatographic method for the analysis of artemisinin in Artemisia annua L. plant extracts; Biomedical Chromatography, (2008); 22: 454-459.
142. Vogel, H., Gonzalez, M., Faini, F., Razmilic, I., Rodriguez, J., San Martin, J., et al.; Antioxidant properties and TLC characterization of four Chilean Haplopappus species known as bailahuén, Journal of Ethnopharmacology, (2005); 97: 97-100.
143. Biringanine, G., Chiarelli, M.T., Faes, M., Duez, P.; A validation protocol for the HPTLC standardization of herbal products: Application to the determination of acteoside in leaves of Plantago palmata Hook. f.s.;Talanta, (2006); 69: 418-424.
144. Vanhaelen-Fastre, R.J., Faes, M.L., Vanhaelen, M.H.; Highperformance thin-layer chromatographic determination of six major ginsenosides in Panax ginseng; Journal of Chromatography A, (2000); 868: 269-276.
145. Cui, S., Fu, B., Sen-Chun Lee, F., Wang, X.; Application of microemulsion thin layer chromatography for the fingerprinting of licorice (Glycyrrhiza spp.); Journal of Chromatography B, (2005); 828: 33-40.
146. Ettre, L.S.; Milestones in the evolution of chromatography. ChromSource, Franklin, TN, (2002).
147. Ciesla, L., Bogucka-Kocka, A., Hajnos, M., Petruczynik, A., Waksmundzka-Hajnosa, M.; Two-dimensional thin-layer chromatography with adsorbent gradient as a method of chromatographic fingerprinting of furanocoumarins for distinguishing selected varieties and forms of Heracleum spp; Journal of Chromatography A,(2008); 1207: 160-168.
148. Ciesla, L., Waksmundzka-Hajnos, M.; Two-dimensional thin-layer chromatography in the analysis of secondary plant metabolites; Journal of Chromatography A, (2009); 1216: 1035-1052.
149. Bombarda, I., Dupuy, N., Le Van Da, J.-P., Gaydou, E.M.; Comparative chemometric analyses of geographic origins and compositions of lavandin var. Grosso essential oils by mid infrared spectroscopy and gas chromatography; Analytica Chimica Acta, (2008); 613: 31-39.
150. Grob, R.L., Barry, E.F.; Modern practice of gas chromatography: 4th edition. Wiley, Hoboken, NJ, (2004).
151. Zhu, H., Wang, Y., Liang, H., Chen, Q., Zhao, P., Tao, J.; Identification of Portulaca oleracea L. from different sources using GC-MS and FT-IR spectroscopy; Talanta, (2010); 81: 129-135.
152. David, F., Gere, D.R., Scanlan, F., Sandra, P.; Instrumentation and applications of fast high-resolution capillary gas chromatography; Journal of Chromatography A, (1999); 842: 309-319.
153. Mondello, L., Shellie, R.A., Casilli, A., Tranchida, P., Marriott, P.J., Dugo, G.; Ultra-fast essential oil characterization by capillary GC on 50 mm ID column; Journal of Separation Science, (2004); 27 699-702.
154. Bicchi, C., Brunelli, C., Cordero, C., Rubiolo, P., Galli, M., Sironi, A.; Direct resistively heated column gas chromatography (ultrafast module-GC) for high-speed analysis of essential oils of differing complexities; Journal of Chromatography A, (2004); 1024: 195-207.
155. Bicchi, C., Brunelli, C., Galli, M., Sironi, A.; Conventional inner diameter short capillary columns: An approach to speeding up gas chromatographic analysis of medium complexity samples; Journal of Chromatography A, (2001); 931: 129-140.
156. Poynter, S.D.H., Shellie, R.A.; High-speed, low-pressure gas chromatography- mass spectrometry for essential oil analysis; Journal of Chromatography A, (2008); 1200: 28-33.
157. Godoi, A.F.L., Vilegas, W., Godoi, R.H.M., Van Vaeck, L., Van Grieken, R.; Application of low-pressure gas chromatography- ion-trap mass spectrometry to the analysis of the essential oil of Turnera diffusa (Ward.) Urb.; Journal of Chromatography A, (2004); 1027: 127-130.
158. Ravindra, K., Dirtu, A.C., Covaci, A.; Low-pressure gas chromatography: Recent trends and developments; Trends in Analytical Chemistry, (2008); 27: 291-303.
159. Mena Granero, A., Egea González, F.J., Garrido Frenich, A., Guerra Sanz, J.M., Martinez Vidal, J.L.; Single step determination of fragrances in Cucurbita flowers by coupling headspace solid-phase microextraction low-pressure gas chromatography-tandem mass spectrometry; Journal of Chromatography A, (2004); 1045: 173-179.
160. Lu, G.H., Chan, K., Liang, Y.Z., Leung, K., Chan, C.L., Jiang, Z.H., et al.; Development of high-performance liquid chromatographic fingerprints for distinguishing Chinese Angelica from related umbelliferae herbs; Journal of Chromatography A, (2005); 1073: 383-392.
161. Li, Y., Wu, T., Zhu, J., Wan, L., Yu, Q., Li, X., et al.; Combinative method using HPLC fingerprint and quantitative analyses for quality consistency evaluation of an herbal medicinal preparation produced by different manufacturers; Journal of Pharmaceutical and Biomedical Analysis, (2010); 52: 597-602.
162. Alaerts, G., Matthijs, N., Smeyers-Verbeke, J., Vander Heyden, Y.; Chromatographic fingerprint development for herbal extracts: A screening and optimization methodology on monolithic columns; Journal of Chromatography A, (2007); 1172: 1-8.
163. Ni, Y., Lai, Y., Brandes, S., Kokot, S.; Multi-wavelength HPLC fingerprints from complex substances: An exploratory chemometrics study of the Cassia seed example; Analytica Chimica Acta, (2009); 647: 149-158.
164. Li, W., Deng, Y., Dai, R., Yu, Y., Saeed, M.K., Li, L., et al.; Chromatographic fingerprint analysis of Cephalotaxus sinensis from various sources by high-performance liquid chromatography- diode array detection-electrospray ionization-tandem mass spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2007): 45: 38-46.
165. Tan, X.J., Li, Q., Chen, X.H., Wang, Z.W., Shi, Z.Y., Bi, K.S., et al.; Simultaneous determination of 13 bioactive compounds in Herba Artemisiae Scopariae (Yin Chen) from different harvest seasons by HPLC-DAD; Journal of Pharmaceutical and Biomedical Analysis, (2008); 47: 847-853.
166. Agnolet, S., Jaroszewski, J.W., Verpoorte, R., Staerk, D.; 1H NMR-based metabolomics combined with HPLC-PDA-MS-SPE-NMR for investigation of standardized Ginkgo biloba preparations; Metabolomics; (2010); 292-302.
167. Ji, Y.B., Xu, Q.S., Hu, Y.Z., Vander Heyden, Y.; Development, optimization and validation of a fingerprint of Ginkgo biloba extracts by high-performance liquid chromatography; Journal of Chromatography A, (2005); 1066: 97-104.
168. Fan, X.H., Cheng, Y.Y., Ye, Z.L., Lin, R.C., Qian, Z.Z.; Multiple chromatographic fingerprinting and its application to the quality control of herbal medicines; Analytica Chimica Acta, (2006); 555: 217-224.
169. Tong, L., Wang, Y., Xiong, J., Cui, Y., Zhou, Y., Yi, L.; Selection and fingerprints of the control substances for plant drug Eucommia ulmodies Oliver by HPLC and LC-MS; Talanta, (2008); 76: 80-84.
170. van Nederkassel, A.M., Vijverman, V., Massart, D.L., Vander Heyden, Y.; Development of a ginkgo biloba fingerprint chromatogram with UV and evaporative light scattering detection and optimization of the evaporative light scattering detector operating conditions. Journal of Chromatography A, (2005); 1085: 230-239.
171. Xie, B., Gong, T., Tang, M., Mi, D., Zhang, X., Liu, J., et al.; An approach based on HPLC-fingerprint and chemometrics to quality consistency evaluation of Liuwei Dihuang Pills produced by different manufacturers; Journal of Pharmaceutical and Biomedical Analysis, (2008); 48: 1261-1266.
172. Faghihi, J., Jiang, X., Vierling, R., Goldman, S., Sharfstein, S., Sarver, J., et al.; Reproducibility of the high-performance liquid chromatographic fingerprints obtained from two soybean cultivars and a selected progeny; Journal of Chromatography A, (2001); 915: 61-74.
173. Wei, H., Sun, L., Tai, Z., Gao, S., Xu, W., Chen, W.; A simple and sensitive HPLC method for the simultaneous determination of eight bioactive components and fingerprint analysis of Schisandra sphenanthera; Analytica Chimica Acta, (2010); 662: 97-104.
174. Lucio-Gutiérrez, J.R., Coello, J., Maspoch, S.; Enhanced chromatographic fingerprinting of herb materials by multi-wavelength selection and chemometrics; Analytica Chimica Acta, (2012); 710: 40-49.
175. Su, J., Fu, P., Shen, Y., Zhang, C., Liang, M., Liu, R., et al.; Simultaneous analysis of flavonoids from Hypericum japonicum Thunb. ex Murray (Hypericaceae) by HPLC-DAD-ESI/MS; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 342-348.
176. Kumar, V., Mehrotra, N., Lal, J., Gupta, R.C.; Pattern profiling of the herbal preparation picroliv using liquid chromatography-tandem mass spectrometry; Journal of Chromatography A, (2004); 1045: 145-152.
177. Dumarey, M., van Nederkassel, A.M., Deconinck, E., Vander Heyden, Y.; Exploration of linear multivariate calibration techniques to predict the total antioxidant capacity of green tea from chromatographic fingerprints; Journal of Chromatography A, (2008); 1192: 81-88.
178. Schneider, A., Wessjohann, L.A.; Comparison of impurity profiles of orlistat pharmaceutical products using HPLC tandem mass spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2010); 53: 767-772.
179. Sacré, P.Y., Deconinck, E., Daszykowski, M., Courselle, P., Vancauwenberghe, R., Chiap, P., et al.; Impurity fingerprints for the identification of counterfeit medicines: A feasibility study; Analytica Chimica Acta, (2011); 701: 224-231.
180. European Directorate for the Quality of Medicines; Draft monograph of sildenafil citrate; Pharmeuropa, (2011); 23: 381-383.
181. European Directorate for the Quality of Medicines; Draft monograph of Tadalafil; Pharmeuropa, (2010); 22: 328-332.
182. van Nederkassel, A.M., Xu, C.J., Lancelin, P., Sarraf, M., Mackenzie, D.A., Walton, N.J., et al.; Chemometric treatment of vanillin fingerprint chromatograms. Effect of different signal alignments on principal component analysis plots; Journal of Chromatography A, (2006); 1120: 291-298.
183. van Nederkassel, A.M., Daszykowski, M., Eilers, P.H., Vander Heyden, Y.; A comparison of three algorithms for chromatograms alignment; Journal of Chromatography A, (2006); 1118: 199-210.
184. Deconinck, E., Sacré, P.Y., Courselle, P.; De Beer, J.O.; Chemometrics and chromatographic fingerprints to discriminate and classify counterfeit medicines containing PDE-5 inhibitors; Talanta, (2012); 100: 123-133.
185. Phillips, G.; Anticounterfeiting measures; Pharmaceutical Journal, (2003); 271: 465.
186. Microgram Bulletin. (2004) http://www.justice.gov/dea/programs/ forensicsci/microgram/mg0604/mg0604.pdf (accessed August 8, 2012).
187. Microgram Bulletin. (2004) http://www.justice.gov/dea/programs/ forensicsci/microgram/mg0404/mg0404.pdf (accessed August 8, 2012).
188. Reepmeyer, J.C., Woodruff, J.T., d'Avignon, D.A.; Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement; Journal of Pharmaceutical and Biomedical Analysis, (2007); 43: 1615-1621.
189. Musshoff, F., Daldrup, T., Ritsch, M.; Anabolic steroids on the German black market; Archiv für Kriminologie, (1997); 199: 152-158.
190. Lin, D.L., Chang, H.C., Huang, S.H.; Characterization of allegedly musk-containing medicinal products in Taiwan; Journal of Forensic Science, (2004); 49: 1187-1193.
191. Soltaninejad, K., Faryadi, M., Akhgari, M., Bahmanabadi, L.; Chemical profile of counterfeit buprenorphine vials seized in Tehran, Iran; Forensic Science International, (2007); 172: e4-5.
192. Alabdalla, M.A.; Chemical characterization of counterfeit captagon tablets seized in Jordan; Forensic Science International, (2005); 152: 185-188.
193. Lee, J.S., Chung, H.S., Kuwayama, K., Inoue, H., Lee, M.Y., Park, J.H.; Determination of impurities in illicit methamphetamine seized in Korea and Japan; Analytica Chimica Acta, (2008); 619: 20-25.
194. Grodowska, K., Parczewski, A.; Organic solvents in the pharmaceutical industry, Acta Poloniae Pharmaceutica, (2010); 67: 3-12.
195. Grodowska, K., Parczewski, A.; Analytical methods for residual solvents determination in pharmaceutical products, Acta Poloniae Pharmaceutica, (2010); 67: 13-26.
196. D'Autry, W., Zheng, C., Wolfs, K., Yarramraju, S., Hoogmartens, J., Van Schepdael, A., et al.; Mixed aqueous solutions as dilution media in the determination of residual solvents by static headspace gas chromatography, Journal of Separation Science, (2011); 34: 1299-1308.
197. D'Autry, W., Zheng, C., Bugalama, J., Wolfs, K., Hoogmartens, J., Adams, E., et al.; Liquid paraffin as new dilution medium for the analysis of high boiling point residual solvents with static headspace-gas chromatography; Journal of Pharmaceutical and Biomedical Analysis, (2011); 55: 1017-1023.
198. D'Autry, W., Wolfs, K., Hoogmartens, J., Adams, E., Van Schepdael, A.; Improving quantitative gas chromatography-electron ionization mass spectrometry results using a modified ion source: demonstration for a pharmaceutical application; Journal of Chromatography A, (2011); 18: 4034-4038.
199. Deconinck, E., Canfyn, M., Sacré, P.Y., Baudewyns, S., Courselle, P., De Beer, J.O.; A validated GC-MS method for the determination and quantification of residual solvents in counterfeit tablets and capsules; Journal of Pharmaceutical and Biomedical Analysis, (2012); 70: 64-70.
200. Mulligan, K.J., Brueggemeyer, T.W., Crockett, D.F., Schepman, J.B.; Analysis of organic volatile impurities as a forensic tool for the examination of bulk pharmaceuticals; Journal of Chromatography A, (1996); 686: 85-95.
201. Deconinck, E., Canfyn, M., Sacré, P.-Y., Courselle, P., De Beer, J.O.; Evaluation of the residual solvent content of counterfeit tablets and capsules; unpublished results.
202. International Conference on Harmonization (ICH); Technical Requirements for the Registration of Pharmaceuticals for Human Use, Q3C. Impurities: Guidelines for Residual Solvents, Step 4 (1997).
203. Marini, R.D., Rozet, E., Montes, M.L., Rohrbasser, C., Roht, S., Rhème, D., et al.; Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines; Journal of Pharmaceutical and Biomedical Analysis, (2010); 53: 1278-1287.
204. Amin, N.C., Blanchin, M.D., Aké, M., Montels, J., Fabre, H.; Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine; Malaria Journal, (2012); 11: 149-156.
205. Lamalle, C., Marini, R.D., Debrus, B., Lebrun, P., Crommen, J., Hubert, P., et al.; Development of a generic micellar electrokinetic chromatography method for the separation of 15 antimalarial drugs as a tool to detect medicine counterfeiting; Electrophoresis, (2012); 33: 1669-1678.
206. Ku, Y.R., Chang, Y.S., Wen, K.C., Ho, L.K.; Analysis and confirmation of synthetic anorexics in adulterated traditional Chinese medicines by high-performance capillary electrophoresis; Journal of Chromatography A, (1999); 848: 537-543.
207. de Carvalho, L.M., Martini, M., Moreira, A.P., Garcia, S.C., do Nascimento, P.C., Bohrer, D.; Determination of synthetic pharmaceuticals in phytotherapeutics by capillary zone electrophoresis with contactless conductivity detection (CE-C4D); Microchemical Journal, (2010); 96: 114-119.
208. Piette, V., Parmentier, F.; Analysis of illicit amphetamine seizures by capillary zone electrophoresis; Journal of Chromatography A, (2002); 979: 345-352.
209. Cianchino, V., Acosta, G., Ortega, C., Martínez, L.D., Gomez, M.R.; Analysis of potential adulteration in herbal medicines and dietary supplements for the weight control by capillary electrophoresis; Food Chemistry, (2008); 108: 1075-1081.
210. Renou-Gonnord, M.F., David, K.; Optimized micellar electrokinetic chromatographic separation of benzodiazepines; Journal of Chromatography A, (1996); 735: 249-261.
211. Berzas, J.J., Castafieda, G., Pinilla, M.J.; Determination of diazepam and associated compounds in pharmaceutical preparations; Fresenius' Journal of Analytical Chemistry, (1999); 364: 570-575.
212. Hancu, G., Gaspár, A., Gyè resi, A.; Separation of 1,4-benzodiazepines by micellar electrokinetic capillary chromatography; Journal of Biochemical and Biophysical Methods, (2007); 69: 251-259.